|
341 |
Intravenous Misuse of Buprenorphine
Enthalten in Clinical drug investigation Bd. 30, 17.9.2012, Nr. 1, date:4.2010: 3-11
|
|
|
|
342 |
Intravenous Vernakalant
Enthalten in Drugs Bd. 71, 18.11.2012, Nr. 2, date:1.2011: 237-252
|
|
|
|
343 |
Intravenous versus Oral Rehydration in Athletes
Enthalten in Sports medicine Bd. 40, 7.10.2012, Nr. 4, date:4.2010: 327-346
|
|
|
|
344 |
Invasive Group A Streptococcal Disease
Enthalten in Drugs Bd. 72, 6.1.2012, Nr. 9, date:9.2012: 1213-1227
|
|
|
|
345 |
Ipilimumab
Enthalten in Drugs in R & D Bd. 10, 27.11.2012, Nr. 2, date:7.2010: 97-110
|
|
|
|
346 |
Is it Time to Retire the ‘Central Governor’?
Enthalten in Sports medicine Bd. 39, 23.10.2012, Nr. 9, date:9.2009: 709-721
|
|
|
|
347 |
Is There a Role for Pharmacoeconomics in Decision Making?
Enthalten in PharmacoEconomics Bd. 30, 27.12.2012, Nr. 10, date:10.2012: 979
|
|
|
|
348 |
Isotretinoin Exposure during Pregnancy
Enthalten in Drug safety Bd. 33, 20.11.2012, Nr. 8, date:8.2010: 659-665
|
|
|
|
349 |
Isotretinoin Use and Compliance with the Dutch Pregnancy Prevention Programme
Enthalten in Drug safety Bd. 33, 20.11.2012, Nr. 4, date:4.2010: 315-326
|
|
|
|
350 |
Issues surrounding orphan disease and orphan drug policies in Europe
Enthalten in Applied health economics and health policy Bd. 8, 6.8.2012, Nr. 5, date:9.2010: 343-350
|
|
Administration
